See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
09:14am, Thursday, Aug 14, 2025
Cassava pivots to TSC epilepsy, trims R&D; cash runway 12 months amid heavy losses, litigation
Cassava Sciences, Inc. (NASDAQ: SAVA) - quick read on what's happening inside the company Snapshot (figures from 10‑Q, all amounts presented by the company in thousands unless noted) * Cash and cash equivalents: $112,381 * Total assets: $135,384 * Total liabilities: $47,411 * Stockholders' equity...
Read More